Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity.
Indian J Ophthalmol
;
2007 Jan-Feb; 55(1): 75-6
Article
in English
| IMSEAR
| ID: sea-70632
ABSTRACT
Aggressive posterior retinopathy of prematurity (formerly known as fulminate/type II/rush disease) occurs in zone 1 or posterior zone 2. Treatment involves extensive near confluent laser ablation of a large area of avascular retina. Anterior segment ischemia is a rare complication that can occur due to injury to the long posterior ciliary arteries in the horizontal meridians during aggressive posterior laser treatment. The outcome of this rare complication is very poor. This case describes a favorable outcome of intravitreal injection of bevacizumab (Avastin) in a case of anterior segment ischemia.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Severity of Illness Index
/
Retinopathy of Prematurity
/
Humans
/
Male
/
Infant, Newborn
/
Angiogenesis Inhibitors
/
Laser Therapy
/
Ischemia
/
Anterior Eye Segment
/
Antibodies, Monoclonal
Language:
English
Journal:
Indian J Ophthalmol
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS